Rema Malik
Vascular Surgery · Houston, TXNPI 1881960169
Payments from drug & device makers
Across 143 payments — averaging $74.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Bard Peripheral Vascular, Inc.$2K
- Silk Road Medical, Inc.$870
- Medtronic$691
- Inari Medical, Inc.$627
- Endologix LLC$485
- plus $3K from 24 others
What the payments were for
- Consulting fees$4694%
- Grants$1411%
- Travel & lodging$2,84827%
- Food & beverage$6,79464%
- Education$4324%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 22 | $2,887 |
| Bard Peripheral Vascular, Inc. | 11 | $1,712 |
| Silk Road Medical, Inc. | 9 | $870 |
| Medtronic(2 entities) | 5 | $691 |
| Inari Medical, Inc. | 23 | $627 |
| Endologix LLC | 4 | $485 |
| Bolton Medical Inc | 4 | $451 |
| W. L. Gore & Associates, Inc. | 6 | $363 |
| Johnson & Johnson(2 entities) | 5 | $333 |
| Cook Medical LLC | 6 | $274 |
| Angiodynamics, Inc. | 9 | $244 |
| Janssen Scientific Affairs, LLC | 4 | $223 |
| Royal Biologics, Inc. | 1 | $173 |
| Aroa Biosurgery Incorporated | 2 | $165 |
| Cook Incorporated | 1 | $141 |
| Shockwave Medical, Inc | 2 | $135 |
| Terumo Medical Corporation | 1 | $126 |
| Organogenesis Inc. | 6 | $125 |
| Stryker | 4 | $123 |
| ETS Wound Care LLC | 3 | $94 |
| Abbott | 4 | $90 |
| Penumbra, Inc. | 1 | $81 |
| Ossur Americas, Inc. | 2 | $53 |
| Solventum Corporation | 1 | $43 |
| Smith+Nephew | 2 | $40 |
| Polynovo North America LLC | 1 | $40 |
| Surmodics, Inc. | 1 | $31 |
| Medline Industries LP | 1 | $30 |
| Lemaitre Vascular, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EKOSONIC$1,653
- VENOVO$956
- ENROUTE Transcarotid Neuroprotection System$953
- ENROUTE Transcarotid Stent$790
- AngioJet Ultra 5000A$469
- Varithena Administration Pack$389
- CT THROMBECTOMY SYSTEM KIT$310
- FLOWTRIEVER CATHETER, S$310
- Relay Grafts$288
- RotarexS 6 F x 135 cm$257
- GLIDESHEATH SLENDER$253
- Venclose Maven Catheter$207
- Torus Stent Graft System$167
- Abre$167
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$163
- GENERAL VASCULAR INTERVENTION$146
- Alto Abdominal Stent Graft System$142
- Endurant$134
- Grafts$131
- GORE VIABAHN VBX Balloon Expandable Endo$127
How this compares
$10,684 in reported general payments places this provider in the 60th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 25 | $15,575 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 54 | $648 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $333 | $15,57525 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in Houston
- Alan LumsdenHouston$2.4M
- Gustavo OderichHouston$999K
- Samuel LeonardHouston$431K
- Ali AzizzadehHouston$387K
- Jean BismuthHouston$382K
- Kristofer Charlton-OuwHouston$240K
- Maham RahimiHouston$221K
- Jayer ChungHouston$179K
- Steven MaximusHouston$140K
- Charudatta BavareHouston$130K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.